Li & Partners has advised Vital Group Holdings Limited (“Vital Group”) (stock code: 1164), a main board listed company, in connection with the allotment and issuance of new shares at a total consideration of HK$384,100,000 and the issuance of convertible bonds in the principal amount of HK$600,000,000 to China Uranium Development Company Limited (“China Uranium”). The transaction was announced on 31 March 2011 and was completed on 18 August 2011. China Uranium has applied for a whitewash waiver to the Securities and Futures Commission and was granted the waiver from a general offer obligation pursuant to the Hong Kong Code on Takeovers and Mergers. After completion, China Uranium controls more than 50.11% interest in Vital Group and is the largest shareholder.